Cargando…
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors
Broadly neutralizing antibodies (bnAbs) to the HIV envelope (Env) V2-apex region are important leads for HIV vaccine design. Most V2-apex bnAbs engage Env with an uncommonly long heavy-chain complementarity-determining region 3 (HCDR3), suggesting that the rarity of bnAb precursors poses a challenge...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671094/ https://www.ncbi.nlm.nih.gov/pubmed/36179689 http://dx.doi.org/10.1016/j.immuni.2022.09.001 |
_version_ | 1784832468651606016 |
---|---|
author | Willis, Jordan R. Berndsen, Zachary T. Ma, Krystal M. Steichen, Jon M. Schiffner, Torben Landais, Elise Liguori, Alessia Kalyuzhniy, Oleksandr Allen, Joel D. Baboo, Sabyasachi Omorodion, Oluwarotimi Diedrich, Jolene K. Hu, Xiaozhen Georgeson, Erik Phelps, Nicole Eskandarzadeh, Saman Groschel, Bettina Kubitz, Michael Adachi, Yumiko Mullin, Tina-Marie Alavi, Nushin B. Falcone, Samantha Himansu, Sunny Carfi, Andrea Wilson, Ian A. Yates, John R. Paulson, James C. Crispin, Max Ward, Andrew B. Schief, William R. |
author_facet | Willis, Jordan R. Berndsen, Zachary T. Ma, Krystal M. Steichen, Jon M. Schiffner, Torben Landais, Elise Liguori, Alessia Kalyuzhniy, Oleksandr Allen, Joel D. Baboo, Sabyasachi Omorodion, Oluwarotimi Diedrich, Jolene K. Hu, Xiaozhen Georgeson, Erik Phelps, Nicole Eskandarzadeh, Saman Groschel, Bettina Kubitz, Michael Adachi, Yumiko Mullin, Tina-Marie Alavi, Nushin B. Falcone, Samantha Himansu, Sunny Carfi, Andrea Wilson, Ian A. Yates, John R. Paulson, James C. Crispin, Max Ward, Andrew B. Schief, William R. |
author_sort | Willis, Jordan R. |
collection | PubMed |
description | Broadly neutralizing antibodies (bnAbs) to the HIV envelope (Env) V2-apex region are important leads for HIV vaccine design. Most V2-apex bnAbs engage Env with an uncommonly long heavy-chain complementarity-determining region 3 (HCDR3), suggesting that the rarity of bnAb precursors poses a challenge for vaccine priming. We created precursor sequence definitions for V2-apex HCDR3-dependent bnAbs and searched for related precursors in human antibody heavy-chain ultradeep sequencing data from 14 HIV-unexposed donors. We found potential precursors in a majority of donors for only two long-HCDR3 V2-apex bnAbs, PCT64 and PG9, identifying these bnAbs as priority vaccine targets. We then engineered ApexGT Env trimers that bound inferred germlines for PCT64 and PG9 and had higher affinities for bnAbs, determined cryo-EM structures of ApexGT trimers complexed with inferred-germline and bnAb forms of PCT64 and PG9, and developed an mRNA-encoded cell-surface ApexGT trimer. These methods and immunogens have promise to assist HIV vaccine development. |
format | Online Article Text |
id | pubmed-9671094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cell Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96710942022-11-18 Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors Willis, Jordan R. Berndsen, Zachary T. Ma, Krystal M. Steichen, Jon M. Schiffner, Torben Landais, Elise Liguori, Alessia Kalyuzhniy, Oleksandr Allen, Joel D. Baboo, Sabyasachi Omorodion, Oluwarotimi Diedrich, Jolene K. Hu, Xiaozhen Georgeson, Erik Phelps, Nicole Eskandarzadeh, Saman Groschel, Bettina Kubitz, Michael Adachi, Yumiko Mullin, Tina-Marie Alavi, Nushin B. Falcone, Samantha Himansu, Sunny Carfi, Andrea Wilson, Ian A. Yates, John R. Paulson, James C. Crispin, Max Ward, Andrew B. Schief, William R. Immunity Article Broadly neutralizing antibodies (bnAbs) to the HIV envelope (Env) V2-apex region are important leads for HIV vaccine design. Most V2-apex bnAbs engage Env with an uncommonly long heavy-chain complementarity-determining region 3 (HCDR3), suggesting that the rarity of bnAb precursors poses a challenge for vaccine priming. We created precursor sequence definitions for V2-apex HCDR3-dependent bnAbs and searched for related precursors in human antibody heavy-chain ultradeep sequencing data from 14 HIV-unexposed donors. We found potential precursors in a majority of donors for only two long-HCDR3 V2-apex bnAbs, PCT64 and PG9, identifying these bnAbs as priority vaccine targets. We then engineered ApexGT Env trimers that bound inferred germlines for PCT64 and PG9 and had higher affinities for bnAbs, determined cryo-EM structures of ApexGT trimers complexed with inferred-germline and bnAb forms of PCT64 and PG9, and developed an mRNA-encoded cell-surface ApexGT trimer. These methods and immunogens have promise to assist HIV vaccine development. Cell Press 2022-11-08 /pmc/articles/PMC9671094/ /pubmed/36179689 http://dx.doi.org/10.1016/j.immuni.2022.09.001 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Willis, Jordan R. Berndsen, Zachary T. Ma, Krystal M. Steichen, Jon M. Schiffner, Torben Landais, Elise Liguori, Alessia Kalyuzhniy, Oleksandr Allen, Joel D. Baboo, Sabyasachi Omorodion, Oluwarotimi Diedrich, Jolene K. Hu, Xiaozhen Georgeson, Erik Phelps, Nicole Eskandarzadeh, Saman Groschel, Bettina Kubitz, Michael Adachi, Yumiko Mullin, Tina-Marie Alavi, Nushin B. Falcone, Samantha Himansu, Sunny Carfi, Andrea Wilson, Ian A. Yates, John R. Paulson, James C. Crispin, Max Ward, Andrew B. Schief, William R. Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors |
title | Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors |
title_full | Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors |
title_fullStr | Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors |
title_full_unstemmed | Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors |
title_short | Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors |
title_sort | human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting hiv v2-apex broadly neutralizing antibody precursors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671094/ https://www.ncbi.nlm.nih.gov/pubmed/36179689 http://dx.doi.org/10.1016/j.immuni.2022.09.001 |
work_keys_str_mv | AT willisjordanr humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT berndsenzacharyt humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT makrystalm humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT steichenjonm humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT schiffnertorben humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT landaiselise humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT liguorialessia humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT kalyuzhniyoleksandr humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT allenjoeld humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT baboosabyasachi humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT omorodionoluwarotimi humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT diedrichjolenek humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT huxiaozhen humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT georgesonerik humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT phelpsnicole humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT eskandarzadehsaman humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT groschelbettina humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT kubitzmichael humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT adachiyumiko humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT mullintinamarie humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT alavinushinb humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT falconesamantha humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT himansusunny humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT carfiandrea humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT wilsoniana humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT yatesjohnr humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT paulsonjamesc humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT crispinmax humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT wardandrewb humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors AT schiefwilliamr humanimmunoglobulinrepertoireanalysisguidesdesignofvaccineprimingimmunogenstargetinghivv2apexbroadlyneutralizingantibodyprecursors |